sponsored by an innovative medicines canada company
.
.
.
.
stephen silberstein, md, director, jefferson university headache center.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
.